LWLauren E. Wedekind

Lauren E. Wedekind

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lauren E. Wedekind has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Sayuko Kobes

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, USA

    3 shared publications
  • Fritz Gerald Paguiligan Kalaw

    Jacobs Retina Center, University of California, San Diego, USA

    2 shared publications
  • Leslie J. Baier

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, USA

    2 shared publications
  • Madhumita Sinha

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, USA

    2 shared publications
  • Muideen T. Olaiya

    Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health Monash University Clayton Victoria Australia

    2 shared publications
  • Robert L. Hanson

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, USA

    2 shared publications

Latest Publications

  • Open Access

    Automated Assessment of OCT Angiography Image Quality Using the Artificial Intelligence Ready and Exploratory Atlas for Diabetes Insights Data Set

    by Jimmy S. Chen, Lauren E. Wedekind, Akshara Legala, Kevin Tenerelli, Jesse Most, Naren Ramesh, Lina Vo, Jooyoung Chang, Kyle Marra, Xinyi Ding, et al.

  • Open Access

    Ophthalmic care at an academic medical centre for patients who were incarcerated or in immigration detention

    by Lauren E. Wedekind, Jimmy S. Chen, Timothy Sestak, Logan H. Sigua, Jazmyn M. Yap, Sidney Lin, Fritz Gerald P. Kalaw, Kyle V. Marra, Jeffrey E. Lee, Nathan L. Scott

    Background/Objectives: Ophthalmic care for patients who are incarcerated or in immigration detention presents complex challenges for patients and providers. There remains a paucity of literature investigating ophthalmic care for these marginalised populations. We investigated the delivery of ophthalmic care in an academic health system to patients who were incarcerated or in immigration detention. Subjects/Methods: We conducted a retrospective observational study and secondary analysis of electronic health record data for inpatient, outpatient, and surgical visits between 1 November 2018 and 30 September 2023 in an ophthalmology department at an academic medical centre in the United States for patients who were incarcerated or in immigration detention. Attendance at outpatient clinic visits and follow-up based on ophthalmic subspecialty, loss to follow-up, delays in follow-up, and rates of ancillary testing were analysed. Results: 1628 scheduled visits were extracted for 401 patients, of which 1084 were attended (2.7 ± 3.6 per patient) and 544 were cancelled or no-showed (1.4 ± 1.8 per patient). Patients attended 100 (68.5%) of cornea, 116 (64.4%) of glaucoma, 2 (28.6%) of neuro-ophthalmology, 139 (58.2%) oculoplastics, 9 (36.0%) of paediatrics/strabismus, and 109 (54.5%) of retina visits. Using a 2-week grace period for follow-up, 72 patients (40.9% with complete follow-up data) completed follow-up within 2 weeks. 229 patients (57.1%) were lost to follow-up at the end of the study period, which is consistent with data from previous reports on ophthalmic care at other centres for patients who were incarcerated. Conclusions: Delays in care and visit attrition were substantial for patients who were incarcerated or in immigration detention. More work is needed to quantify outcomes and address disparities in care for these marginalised communities.


  • Open Access

    Ophthalmic Care at an Academic Medical Centre for Patients who were Incarcerated or in Immigration Detention

    by Lauren Wedekind, Jimmy Chen, Timothy Sestak, Logan Sigua, Jazmyn Yap, Sidney Lin, Fritz Gerald Kalaw, Kyle Marra, Jeffrey Lee, Nathan Scott

    Background/Objectives: Ophthalmic care for patients who are incarcerated or in immigration detention presents complex challenges for patients and providers. There remains a paucity of literature investigating ophthalmic care for these marginalised populations. We investigated delivery of ophthalmic care in an academic health system to patients who were incarcerated or in immigration detention. Subjects/Methods: We conducted a retrospective observational study and secondary analysis of electronic health record data for inpatient, outpatient, and surgical visits between 1 November 2018 and 30 September 2023 in an ophthalmology department at an academic medical centre in the United States for patients who were incarcerated or in immigration detention. Attendance at outpatient clinic visits and follow-up based on ophthalmic subspecialty, loss to follow-up, delays in follow-up, rates of ancillary testing were analysed. Results: 1628 visits were extracted for 401 patients, for which 1084 were attended [2.7 ± 3.6 per patient] and 544 were canceled or no-showed [1.4 ± 1.8 per patient]. Patients attended 100 [68.5%] of cornea, 116 [64.4%] of glaucoma, 2 [28.6%] of neuro-ophthalmology, 139 [58.2%] oculoplastics, 9 [36.0%] of paediatrics/strabismus, and 109 [54.5%] of retina visits. Using a 2-week grace period for follow-up, 72 patients (40.9% with complete follow-up data) completed follow-up within 2 weeks. 229 patients (57.1%) were lost to follow-up at the end of the study period. Conclusions: Delays in care and visit attrition were substantial for patients who were incarcerated or in immigration detention. More work is needed to quantify outcomes and address disparities in care for these marginalised communities.


  • Open Access

    The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population

    by Lauren E. Wedekind, Anubha Mahajan, Wen-Chi Hsueh, Peng Chen, Muideen T. Olaiya, Sayuko Kobes, Madhumita Sinha, Leslie J. Baier, William C. Knowler, Mark I. McCarthy, et al.

    Aims/hypothesis: There is limited information on how polygenic scores (PSs), based on variants from genome-wide association studies (GWASs) of type 2 diabetes, add to clinical variables in predicting type 2 diabetes incidence, particularly in non-European-ancestry populations. Methods: For participants in a longitudinal study in an Indigenous population from the Southwestern USA with high type 2 diabetes prevalence, we analysed ten constructions of PS using publicly available GWAS summary statistics. Type 2 diabetes incidence was examined in three cohorts of individuals without diabetes at baseline. The adult cohort, 2333 participants followed from age ≥20 years, had 640 type 2 diabetes cases. The youth cohort included 2229 participants followed from age 5–19 years (228 cases). The birth cohort included 2894 participants followed from birth (438 cases). We assessed contributions of PSs and clinical variables in predicting type 2 diabetes incidence. Results: Of the ten PS constructions, a PS using 293 genome-wide significant variants from a large type 2 diabetes GWAS meta-analysis in European-ancestry populations performed best. In the adult cohort, the AUC of the receiver operating characteristic curve for clinical variables for prediction of incident type 2 diabetes was 0.728; with the PS, 0.735. The PS’s HR was 1.27 per SD (p=1.6 × 10−8; 95% CI 1.17, 1.38). In youth, corresponding AUCs were 0.805 and 0.812, with HR 1.49 (p=4.3 × 10−8; 95% CI 1.29, 1.72). In the birth cohort, AUCs were 0.614 and 0.685, with HR 1.48 (p=2.8 × 10−16; 95% CI 1.35, 1.63). To further assess the potential impact of including PS for assessing individual risk, net reclassification improvement (NRI) was calculated: NRI for the PS was 0.270, 0.268 and 0.362 for adult, youth and birth cohorts, respectively. For comparison, NRI for HbA1c was 0.267 and 0.173 for adult and youth cohorts, respectively. In decision curve analyses across all cohorts, the net benefit of including the PS in addition to clinical variables was most pronounced at moderately stringent threshold probability values for instituting a preventive intervention. Conclusions/interpretation: This study demonstrates that a European-derived PS contributes significantly to prediction of type 2 diabetes incidence in addition to information provided by clinical variables in this Indigenous study population. Discriminatory power of the PS was similar to that of other commonly measured clinical variables (e.g. HbA1c). Including type 2 diabetes PS in addition to clinical variables may be clinically beneficial for identifying individuals at higher risk for the disease, especially at younger ages. Graphical


  • 1701-P: Genome-Wide Association Study Identifies Novel Potential Associations with Birth Weight in a Southwestern American Indian Population

    by Lauren E. Wedekind, Wen-Chi Hsueh, Sayuko Kobes, Muideen T. Olaiya, William C. Knowler, Leslie J. Baier, Robert L. Hanson

    Epidemiologic studies in many populations have shown that birth weight is associated with risk of type 2 diabetes (T2D) in adulthood. In a Southwestern American Indian population, lower and higher birth weight groups are at higher risk for T2D than those with normal birth weight. We performed a genome-wide association study (GWAS) of birth weight in 3700 Southwestern American Indians (2037 female; 1663 male). 496,190 SNPs (allele frequency>1%) were directly genotyped using an Axiom array designed to capture common variation in this community (Affymetrix; Santa Clara, CA). Birth weight was ascertained from Arizona state and medical records. T2D was determined according to American Diabetes Association criteria at a research exam or during clinical care. Birth weight data were normalized separately by sex and analyzed for genetic associations using a mixed model (SOLAR-Eclipse; Catonsville, MD) accounting for genetic relationships (based on genetic markers among all pairs of individuals) and adjusted for birth year and the 1st 5 genetic principal components. We identified 41 variants suggestively associated (p<0.0001) with birth weight. The strongest associations are with rs4799141 in PARD6G (β=-0.14 SD per T allele; p=7.5E-6), rs17333221 in MEOX2 (β=-0.15 SD per C allele; p=1.0E-5), rs11704996 in TRIOBP (β=0.15 SD per A allele; p=1.0E-5) and a missense variant in ABCC8, R1420H (β=0.41 SD per H allele; p=1.5E-5). 5 of the 41 variants are also nominally associated with T2D (p<0.05) in 7659 individuals from this population; the most notable was the R1420H variant in ABCC8, which we previously reported as associated with T2D (OR=2.2, p=3.0E-5) and for which activating mutations cause hyperinsulinemic hypoglycemia of infancy. In sum, we identified novel suggestive genetic associations with birth weight, which require confirmation in additional studies, and show that R1420H in ABCC8 is a strong genetic determinant of birth weight in this population. Disclosure L.E. Wedekind: None. W. Hsueh: None. S. Kobes: None. M.T. Olaiya: None. W.C. Knowler: None. L.J. Baier: None. R.L. Hanson: None.

  • Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes

    by Muideen T. Olaiya, Lauren E. Wedekind, Robert L. Hanson, Madhumita Sinha, Sayuko Kobes, Robert G. Nelson, Leslie J. Baier, William C. Knowler

    Aims/hypothesis The aim of this work was to estimate the impact of birthweight on early-onset (age p < 0.001) and a negative linear effect at older age intervals (20–29 years, p < 0.001; 30–39 years, p = 0.003). Higher GRS, greater BMI and maternal diabetes had additive but not interactive effects on the association between birthweight and diabetes incidence. Conclusions/interpretation In this high-risk population, both low and high birthweights were associated with increased type 2 diabetes risk in adolescence (age 10–19 years) but only low birthweight was associated with increased risk in young adulthood (20–39 years). Higher type 2 diabetes GRS, greater BMI and maternal diabetes added to the risk of early-onset diabetes.


  • Open Access

    Supply and Perceived Demand for Teleophthalmology in Triage and Consultations in California Emergency Departments

    by Lauren Wedekind, Kristin Sainani, Suzann Pershing

    Rural emergency departments often have limited resources relative to nonrural emergency departments and patients may face inequities in access to quality emergency care based on their proximity to health care facilities.1 These geographic differences in resources result in coverage gaps, which are more severe for access to specialized care such as ophthalmology.2 Approximately 18 805 board-certified ophthalmologists practice in the United States, with disproportionately more in nonrural vs rural regions.3 Prior studies have demonstrated that the likelihood of adults with diabetes receiving annual dilated eye examinations is reduced in areas with a lower geographic density of eye care professionals.4 Currently, there is a lack of published literature on the unavailability of on-call ophthalmologists for emergency eye care.